AdvanSix Q3 2026 sales up 15% despite adjusted EPS loss
Advansix reported Q326 sales of $431 million, up 15% year-over-year, while adjusted diluted EPS was negative ($0.24) due to reduced output and higher input costs. The company also secured a $47 million Fields Grant for its ammonia platform.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed